| Online-Ressource |
Verfasst von: | Renner, Andreas [VerfasserIn]  |
| Stoshikj, Slagjana [VerfasserIn]  |
| Pohl, Wolfgang [VerfasserIn]  |
| Bal, Christina [VerfasserIn]  |
| Reisinger, Matthias [VerfasserIn]  |
| Löffler-Ragg, Judith [VerfasserIn]  |
| Zacharasiewicz, Angela [VerfasserIn]  |
| Buhl, Roland [VerfasserIn]  |
| Hamelmann, Eckard [VerfasserIn]  |
| Taube, Christian [VerfasserIn]  |
| Korn, Stephanie [VerfasserIn]  |
| Idzko, Marco [VerfasserIn]  |
Titel: | Characterization of Austrian severe asthma patients |
Verf.angabe: | Andreas Renner, Slagjana Stoshikj, Wolfgang Pohl, Christina Bal, Matthias Reisinger, Judith Löffler-Ragg, Angela Zacharasiewicz, Roland Buhl, Eckard Hamelmann, Christian Taube, Stephanie Korn, Marco Idzko |
E-Jahr: | 2023 |
Jahr: | 10 October 2023 |
Umfang: | 8 S. |
Illustrationen: | Diagramme |
Fussnoten: | Gesehen am 18.03.2024 |
Titel Quelle: | Enthalten in: Respiratory medicine |
Ort Quelle: | Burlington, Mass. : Harcourt, 1999 |
Jahr Quelle: | 2023 |
Band/Heft Quelle: | 219(2023) vom: Nov./Dez., Artikel-ID 107427, Seite 1-8 |
ISSN Quelle: | 1532-3064 |
Abstract: | Introduction - The Severe Asthma Registry, founded by German Asthma Net (GAN) in 2011, is a prospective registry recording clinical parameters from participating centers in Germany, Austria and Switzerland. This article presents the baseline characteristics of severe asthma patients from Austrian centers. - Methods - We analyzed the baseline visit data of all patients recruited to the GAN Severe Asthma Registry from participating Austrian centers. - Results - Baseline visit data were available for 214 Austrian severe asthma patients from 6 Austrian centers from 2013 to 2022. Mean age was 53.7 years. Mean BMI was 26.4 kg/m2. More than a third (37.4%) of all patients had daily daytime asthma symptoms at baseline and had to use their reliever medication at least once per day. Forty-one percent of patients were classified as uncontrolled according to GINA and 24.8% as partially controlled at baseline visit. The median annual exacerbation frequency was 3 in the previous 12 months. At the time of baseline visit, 23.4% of all patients had regular treatment with oral corticosteroids. Furthermore, 23.9% had received any severe asthma monoclonal antibody prior to the baseline visit. There were no notable differences in baseline characteristics between patients categorized by smoking history or measurable type 2 inflammation. - Conclusions - This study provides the first multi-center characterization of Austrian severe asthma patients. Patients in this cohort had better asthma control and less frequent exacerbations compared to most international registries. |
DOI: | doi:10.1016/j.rmed.2023.107427 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: https://doi.org/10.1016/j.rmed.2023.107427 |
| kostenfrei: Volltext: https://www.sciencedirect.com/science/article/pii/S0954611123003153 |
| DOI: https://doi.org/10.1016/j.rmed.2023.107427 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Asthma |
| Asthma control |
| Biologics |
| Registry data |
| Severe asthma |
| Type-2-inflammation |
K10plus-PPN: | 1883657008 |
Verknüpfungen: | → Zeitschrift |
Characterization of Austrian severe asthma patients / Renner, Andreas [VerfasserIn]; 10 October 2023 (Online-Ressource)